Trial
NCT04784143
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Resilient Pharmaceuticals
Collaborators
—
Condition
PTSD
Intervention
Midomafetamine
Why stopped
The study was terminated early by the sponsor due to administrative, non-safety related reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-15